Cooper Companies

The Cooper Cos, Inc. operates as a medical device company. It operates through the Cooper Vision and Cooper Surgical segments. The Cooper Vision segment develops, manufactures, and markets products for contact lens wearers, which solves vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues. The Cooper Surgical segment focuses on the provision of advancement for the health of women, babies, and families through women's health and fertility products and services. The company was founded in 1958 and is headquartered in San Ramon, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Cooper Companies excels in Q1, eyes growth through strategic initiatives

Cooper Companies delivered exceptional Q1 results, surpassing revenue and earnings expectations. With a focus on innovation, operational efficiency, and strategic acquisitions, the company is well-positioned for continued growth despite economic uncertainties and supply chain challenges.

Cooper Companies reports record Q2 revenues amidst industry challenges

Cooper Companies delivered a strong Q2 performance with record revenues and solid earnings per share, driven by CooperVision and CooperSurgical.
While facing industry-wide supply chain challenges, Cooper's strategic strengths in product portfolios and geographic diversification position it well for future growth.
Opportunities lie in leveraging successful product lines, addressing operational challenges, and expanding into international markets for sustained growth.
Overall, Cooper remains optimistic about its future growth prospects in the contact lens and fertility markets, despite facing some challenges.

Cooper Companies reports record revenues and optimistic outlook for growth

Cooper Companies delivered strong financial performance, exceeding revenue expectations and showcasing growth in key segments. The company is strategically positioned for sustained growth, with a focus on leveraging market opportunities and optimizing infrastructure investments. Challenges in managing growth and SKU ranges are being addressed to drive future profitability.

Cooper Companies reports record revenues and projects strong growth ahead

Cooper Companies had a stellar year, marked by record revenues and robust growth in key segments. Despite challenges in capacity and cash flow, the company is poised for continued success with confidence in overcoming obstacles. Opportunities in Myopia management, price trends, and share gains position Cooper Companies for a promising future.

Cooper Companies reports record Q1 revenues, eyes global growth opportunities

Cooper Companies delivered a strong Q1 performance with record revenues and raised full-year guidance. The company's focus on key growth areas like myopia management and daily contact lenses bodes well for future success. Addressing challenges in capacity constraints and market fluctuations will be crucial for sustained growth.

Cooper Companies (COO) reports record revenues and growth opportunities

Cooper Companies (COO) reports strong Q2 earnings with record revenues and increased guidance for fiscal 2024. Challenges include system upgrade impact and competitive uncertainties, but opportunities lie in market growth and strategic investments for future growth.

Cooper Companies (COO) excels in Q3 with record revenues and growth

Cooper Companies (COO) showcased robust financial performance in Q3 2024, driven by record revenues and earnings growth across its key segments.
While facing challenges in certain product lines, strategic investments and market-leading positions position the company well for future growth and profitability.
With a focus on innovation and operational excellence, Cooper Companies is poised to capitalize on opportunities for sustained success and market expansion.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

SAN RAMON, Calif., Sept. 12, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), today announced that it will transfer the listing of its common stock from the New York Stock Exchange (“NYSE”) to the Nasdaq Stock Market (“Nasdaq”). Cooper expects to begin trading as a Nasdaq-listed company at market open on September 26, 2023, and will continue to trade under the symbol “COO.”

CooperCompanies Announces Transfer of Stock Exchange Listing to Nasdaq

SAN RAMON, Calif., Sept. 11, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), will participate in the Baird Healthcare Conference on Wednesday, September 13, 2023. Brian Andrews, Executive Vice President, Chief Financial Officer & Treasurer, will represent the Company in a session scheduled to begin at 1:25 PM ET.

CooperCompanies to Present at the Baird Healthcare Conference

Marquee industry conference will showcase data from CBR's Newborn Possibilities Program® TRUMBULL, Conn. , Sept. 8, 2023 /PRNewswire/ -- CooperSurgical, a global leader in fertility and women's health, announced that Cord Blood Registry® (CBR®) will have a key role in the upcoming Cord Blood Connect meeting from September 8 th – 11th, which is the annual meeting of the Cord Blood Association.

Cord Blood Registry® Announces Thought Leadership Role at Cord Blood Connect

Cooper Companies' (COO) third-quarter fiscal 2023 revenues reflect a solid segmental performance with improved adjusted earnings amid rising expenses.

Cooper Companies (COO) Q3 Earnings In Line, '23 Outlook Raised

The Cooper Companies, Inc. (NYSE:COO ) Q3 2023 Earnings Call Transcript August 30, 2023 5:00 PM ET Company Participants Kim Duncan - VP of IR & Risk Management Albert White - President and CEO Brian Andrews - Executive VP, CFO & Treasurer Conference Call Participants Jonathan Block - Stifel Lawrence Biegelsen - Wells Fargo Securities Jeffrey Johnson - Robert W. Baird Matthew Mishan - KeyBanc Capital Markets Jason Bednar - Piper Sandler Joanne Wuensch - Citigroup Bradley Bowers - Mizuho Securities Patrick Wood - Morgan Stanley Robbie Marcus - JPMorgan David Saxon - Needham & Company Ron Feiner - Oppenheimer Operator Good afternoon.

The Cooper Companies, Inc. (COO) Q3 2023 Earnings Call Transcript

Although the revenue and EPS for The Cooper Companies (COO) give a sense of how its business performed in the quarter ended July 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

The Cooper Companies (COO) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

The Cooper Companies (COO) came out with quarterly earnings of $3.35 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $3.19 per share a year ago.

The Cooper Companies (COO) Q3 Earnings Match Estimates

Cooper Companies Inc beat quarterly revenue Wall Street estimates on Wednesday, driven by strong demand for its contact lenses.

Cooper Cos beats revenue estimates on strong performance in contact lens unit

SAN RAMON, Calif., Aug. 30, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced financial results for its fiscal third quarter ended July 31, 2023.

CooperCompanies Announces Third Quarter 2023 Results

Cooper Companies (COO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Should You Buy Cooper Companies (COO) Ahead of Earnings?

Cooper Companies' (COO) fiscal third-quarter results are likely to reflect segmental strength.

Is a Beat Likely for Cooper Companies (COO) in Q3 Earnings?

The Cooper Companies (COO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Why The Cooper Companies (COO) is Poised to Beat Earnings Estimates Again

SAN RAMON, Calif., Aug. 02, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), will participate in the Wells Fargo Healthcare Conference on Wednesday, September 6, 2023. Al White, President and CEO, will represent the Company in a session scheduled to begin at 3:00 PM ET.

CooperCompanies to Present at the Wells Fargo Healthcare Conference

SAN RAMON, Calif., July 26, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced it will report third quarter 2023 financial results on Wednesday, August 30, 2023, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments. The dial-in number for the call is 800-715-9871 and the conference ID is 5988827. A simultaneous audio webcast can be accessed on CooperCompanies' investor relations website at http://investor.coopercos.com. A replay of the event will be available on the same webpage following its conclusion.

CooperCompanies Announces Release Date for Third Quarter 2023

Align Technology

Patterson Companies

West Pharmaceutical Services

DENTSPLY SIRONA

Here we discuss five stocks from the Dental Supplies industry that are likely to create wealth for investors. These include WST, ALGN, COO, XRAY and PDCO.

5 Stocks to Buy From the Prospering Dental Supplies Industry

Investors need to pay close attention to The Cooper Companies (COO) stock based on the movements in the options market lately.

Is the Options Market Predicting a Spike in The Cooper Companies (COO) Stock?

SAN RAMON, Calif., July 12, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced that consistent with the plan approved by its board of directors to pay annual dividends, the Company declared a semi-annual dividend of 3 cents per share, payable on August 11, 2023, to stockholders of record on July 27, 2023.

CooperCompanies Declares Cash Dividend

I recommend a hold due to its high valuation, despite strong performance in the contact lens industry. COO's 2Q23 results were solid with sales of $877.4 million, up 8% YoY, and an increase in earnings per share of $3.08, exceeding expectations. The company's net debt is $2.5 billion, or 2.5 times FY23 EBITDA, but this is not seen as a concern due to the COO's consistent cash production.

The Cooper Companies: Valuation Is Too High (Rating Downgrade)

Investors with an interest in Medical - Dental Supplies stocks have likely encountered both Dentsply International (XRAY) and The Cooper Companies (COO). But which of these two stocks is more attractive to value investors?

XRAY vs. COO: Which Stock Is the Better Value Option?

Belite Bio Inc

Clearpoint Neuro Inc

iRhythm Technologies

STAAR Surgical

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Top 5 Health Care Stocks That Are Set To Fly In Q2

The Cooper Companies (COO) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Down -7.64% in 4 Weeks, Here's Why The Cooper Companies (COO) Looks Ripe for a Turnaround

Cooper Companies' (COO) second-quarter fiscal 2023 revenues reflect a solid segmental performance despite a year-over-year decline in earnings.

Cooper Companies (COO) Q2 Earnings and Revenues Beat Estimates

The Cooper Companies, Inc. (NYSE:COO ) Q2 2023 Earnings Conference Call June 1, 2023 5:00 PM ET Company Participants Kim Duncan - - VP of IR & Risk Management Albert White - President and CEO Brian Andrews - Executive VP, CFO & Treasurer Conference Call Participants Jeffrey Johnson - Robert W. Baird Lawrence Biegelsen - Wells Fargo Securities Joanne Wuensch - Citigroup Anthony Petrone - Mizuho Securities Robbie Marcus - JPMorgan Brett Fishbin - KeyBanc Capital Markets Jason Bednar - Piper Sandler Jonathan Block - Stifel Patrick Wood - Morgan Stanley David Saxon - Needham & Company Operator Good afternoon.

The Cooper Companies, Inc. (COO) Q2 2023 Earnings Call Transcript

Although the revenue and EPS for The Cooper Companies (COO) give a sense of how its business performed in the quarter ended April 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

The Cooper Companies (COO) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

The Cooper Companies (COO) came out with quarterly earnings of $3.08 per share, beating the Zacks Consensus Estimate of $3.01 per share. This compares to earnings of $3.24 per share a year ago.

News for Cooper Companies Stock (COO)